by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA new protein risk score developed to predict the risk of death for persons with heart failure (HF) has demonstrated good calibra
by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA new protein risk score developed to predict the risk of death for persons with heart failure (HF) has demonstrated good calibra
by Ernie MundellFeeling angry constricts blood vessels in unhealthy ways and could raise a person's long-term odds for heart disease, new research warns."If you're a person who gets angry
by Ernie MundellFeeling angry constricts blood vessels in unhealthy ways and could raise a person's long-term odds for heart disease, new research warns."If you're a person who gets angry
by Melissa Rohman,Northwestern UniversitySoft lithographic process to generate PC of iPSC-aCMs and CFs within multiwell plates. Green color and purple color indicate the patterned iPSC-aCMs and
by Melissa Rohman,Northwestern UniversitySoft lithographic process to generate PC of iPSC-aCMs and CFs within multiwell plates. Green color and purple color indicate the patterned iPSC-aCMs and
by Ryan O'Hare,Imperial College LondonCredit: Pavel Danilyuk from PexelsChanges to blood pressure over time could be used to identify patients at greatest risk of heart attack and stroke. Th
by Ryan O'Hare,Imperial College LondonCredit: Pavel Danilyuk from PexelsChanges to blood pressure over time could be used to identify patients at greatest risk of heart attack and stroke. Th
by Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Summary of main findings by CNIC researchers. Clonal hematopoiesis and the expansion of blood cells carrying certain acquired
by Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Summary of main findings by CNIC researchers. Clonal hematopoiesis and the expansion of blood cells carrying certain acquired
JANUARY 26, 2024byKing's College LondonCredit:Journal of the American College of Cardiology(2024). DOI: 10.1016/j.jacc.2023.10.034A heart test that has been downgraded in the int
JANUARY 26, 2024byKing's College LondonCredit:Journal of the American College of Cardiology(2024). DOI: 10.1016/j.jacc.2023.10.034A heart test that has been downgraded in the int
by Elana GotkineSpecific combinations of antihypertensives are recommended for patients with Bruton's tyrosine kinase inhibitor (BTKi)-associated hypertension (HTN), according to astudy 
by Elana GotkineSpecific combinations of antihypertensives are recommended for patients with Bruton's tyrosine kinase inhibitor (BTKi)-associated hypertension (HTN), according to astudy 
by Ingebjørg Hestvik,Norwegian University of Science and TechnologyGraphical Abstract. Credit:European Journal of Preventive Cardiology(2023). DOI: 10.1093/eurjpc/zwad365Certain gene
by Ingebjørg Hestvik,Norwegian University of Science and TechnologyGraphical Abstract. Credit:European Journal of Preventive Cardiology(2023). DOI: 10.1093/eurjpc/zwad365Certain gene
by Elana GotkineA bivalent mRNA COVID-19 vaccine after receipt of an original monovalent COVID-19 vaccine is effective for preventing COVID-19-related thromboembolic events, according to research publ
by Elana GotkineA bivalent mRNA COVID-19 vaccine after receipt of an original monovalent COVID-19 vaccine is effective for preventing COVID-19-related thromboembolic events, according to research publ
byAmerican Society of NephrologyCredit: Unsplash/CC0 Public DomainSodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2
byAmerican Society of NephrologyCredit: Unsplash/CC0 Public DomainSodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2
by Elana GotkineAcoramidis yields a significantly better four-step primary hierarchical outcome, including aspects of mortality and morbidity, than placebo for patients with transthyretin amyloid card
by Elana GotkineAcoramidis yields a significantly better four-step primary hierarchical outcome, including aspects of mortality and morbidity, than placebo for patients with transthyretin amyloid card